HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Factors affecting long-term visual outcome in retinopathy of prematurity treated with xenon photocoagulation and/or cryocautery].

Abstract
We evaluated long-term visual outcome in 28 patients (52 eyes) with retinopathy of prematurity after Xenon photocoagulation and/or cryocautery. The visual outcome was roughly classified into two groups: visual acuity of 0.6 or better and that of 0.2 or worse. The poor visual outcome resulted from macular degeneration, and risk factors for its development were small birth weight (Mann-Whitney's U test, p = 0.03), retinopathy plus disease (chi 2 test, p = 0.041), treatment of a large area of the fundus (Mann-Whitney's U test, p = 0.035) and the inside of the vascular arcade (Mann-Whitney's U test, p = 0.0034), and treatment by cryocautery (chi 2 test, p = 0.032). Macular degeneration occurred either as an isolated small focus extending circumferentially around the fovea or as a result of extension from the temporal degeneration caused by photocoagulation. These results suggest that intensive treatment for retinopathy of prematurity, in addition to the prematurity by itself, caused the development of macular degeneration. Overtreatment should be carefully avoided in retinopathy of prematurity complicated by disease in which photocoagulation needs to be done in the area posterior to the ridge.
AuthorsM Noso
JournalNippon Ganka Gakkai zasshi (Nippon Ganka Gakkai Zasshi) Vol. 101 Issue 6 Pg. 503-9 (Jun 1997) ISSN: 0029-0203 [Print] Japan
PMID9209138 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Xenon
Topics
  • Birth Weight
  • Cryosurgery (adverse effects)
  • Humans
  • Infant, Newborn
  • Light Coagulation (adverse effects)
  • Macular Degeneration (etiology, pathology)
  • Retinopathy of Prematurity (physiopathology, surgery)
  • Retrospective Studies
  • Risk Factors
  • Treatment Outcome
  • Visual Acuity
  • Xenon

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: